-

Trinity Life Sciences Names First Chief Technology Officer

Rajeev Rangachari Plans to Bolster a Culture of Innovation

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced the appointment of Rajeev Rangachari to serve as the Company’s first-ever Chief Technology Officer (CTO). Mr. Rangachari brings significant experience in building flexible, scalable solutions for life sciences organizations to Trinity.

As CTO, Mr. Rangachari will infuse technology into every aspect of Trinity’s offerings and workflow, accelerating business processes with technology assets. He will lead a global team of technologists and life sciences domain experts as they focus on the new opportunities in Artificial Intelligence (AI), drive innovation in spaces that aren’t traditionally tech-enabled and ensure adoption of best practices in security and compliance.

“Generative AI and, more broadly, AIML in all its forms will be transformative for life sciences in the next few years. As we tackle these technological disruptions on behalf of our clients, having a seasoned technology leader in the new CTO role is vital,” explained Leslie Orne, President & CEO of Trinity Life Sciences. “I am delighted Rajeev is on the team and bringing his high-energy, outcomes-focused leadership style and unique skillset to bear on these crucial initiatives.”

“From a global life sciences technology perspective, the power of Generative AI provides an opportunity to bring people without technical backgrounds into the leading edge of data science,” added Rajeev Rangachari, CTO of Trinity Life Sciences. “I am honored to lead Trinity’s technology strategy at such an exciting moment and look forward to bolstering an already innovative culture by enhancing and developing world-class tools and technology that support life sciences commercialization.”

Prior to accepting the CTO role, Mr. Rangachari most recently served as D Cube Analytics’ Chief Technology Officer. D Cube Analytics was acquired by Trinity Life Sciences in July 2022.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With more than 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom